Indefinite Delivery Contract HHSN272201700020I
Ended Awarded Last action
- Contract number
- HHSN272201700020I
- Awardee
-
Pharmacology Discovery Services Taiwan, LTD. UEI MXP1NVQ8C1J8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 16 $10,643,445 obligated
Award facts
- Opportunity
-
- NIHAI2016059 Solicitation number
- Pre-clinical models of infectious diseases Award Notice · Posted Apr 29, 2016
- Combined order value
-
- $11,132,665 Current, with exercised options
- $16,525,588 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 27% used
- $40,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 67 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a multiple-award indefinite-delivery contract to Pharmacology Discovery Services Taiwan, LTD. with a $40 million ceiling on July 13, 2017.
The IDIQ supports preclinical models of infectious diseases, enabling NIAID to procure murine and other animal models for screening and evaluating medical countermeasures including therapeutics, vaccines, and diagnostics. Work is performed in Taiwan, St. Charles, Missouri, Rockville, Maryland, and other locations as required.
Period of performance runs from July 13, 2017 through July 13, 2024 (note: source metadata indicates an ultimate completion date of July 13, 2024, though the vendor summary references a separate single-award contract running through July 2031—this summary addresses only the 2017–2024 IDIQ identified as the contract parent in all delivery orders).
Delivery orders issued under this IDIQ have ranged from $620 to $1.87 million. Recent task orders include a $1.87 million delivery order for a mouse model of Neisseria gonorrhoeae infection (awarded July 12, 2024, completing July 11, 2025); a $754,505 order for testing in murine models of bacterial infection (awarded July 10, 2024, completing July 9, 2025); and a $1.24 million order for preclinical models including antibiotic-resistant urinary tract infections (awarded August 31, 2023, completing February 7, 2025). All orders are firm fixed price or cost-based, with no set-asides applied.
Task orders
Show all 16
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN272201700020I?
HHSN272201700020I was awarded to Pharmacology Discovery Services Taiwan, LTD. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 13, 2017.
How much is contract HHSN272201700020I worth?
Orders under HHSN272201700020I have obligated $10,643,445. Their combined current value, with exercised options, is $11,132,665. Their combined potential value, with all options, is $16,525,588. HHSN272201700020I's own ceiling is $40,000,000.
How many orders have been placed under contract HHSN272201700020I?
16 orders have been placed under HHSN272201700020I, the latest on July 12, 2024.
Who can order from contract HHSN272201700020I?
HHSN272201700020I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN272201700020I part of a contract vehicle?
Yes. HHSN272201700020I is part of NIAID Preclinical Models of Infectious Diseases 2017-2024.
Was contract HHSN272201700020I competed?
The extent of competition for HHSN272201700020I was full and open competition. The government received 67 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV